CD163 and hemophagocytic syndrome: The soluble interleukin-2 receptor alpha chain (sCD25) and the soluble haptoglobin-hemoglobin receptor complex (sCD163) have been used as biomarkers in the diagnosis and surveillance of hemophagocytic lymphohistiocytosis (HLH) activity.